Eisai, Takeda Follow Differing Japan Treatments For Alzheimer’s Disease
This article was originally published in PharmAsia News
Executive Summary
Eisai and Takeda Pharmaceutical have stepped in to fill a vacuum of drugs to treat Alzheimer’s disease, each working on treatments either to halt development of the disease or to reverse it.